Mesirow Financial Investment Management, Inc. Amicus Therapeutics, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.9 Billion
- Q1 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 13,000 shares of FOLD stock, worth $78,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,000
Previous 16,936
23.24%
Holding current value
$78,780
Previous $159,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding FOLD
# of Institutions
309Shares Held
321MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$177 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$148 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$130 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$124 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...